Attached files
| file | filename |
|---|---|
| 8-K - FLUOROPHARMA MEDICAL, INC. | form8k-08222012_020845.htm |
Exhibit 16.1
August 17, 2012
Securities and Exchange Commission
Office of the Chief Accountant
100 F Street NE
Washington DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of the Form 8-K dated August 17, 2012 of FluoroPharma Medical Inc. and are in agreement with the statements insofar as they relate to our firm.
We have no basis to agree or disagree with the other statements of the registrant contained therein.
